What's Happening?
HighRes and Waters Biosciences have announced a strategic collaboration to integrate robotic capabilities into Waters' flow cytometers. This integration aims to automate complex experimental steps, enhancing research workflows from basic research to drug
discovery. The collaboration involves the use of HighRes' Nucleus Automation and Cellario Software Platforms with Waters' BD FACSLyric Flow Cytometer. This integration allows for unattended, continuous operation, enabling up to three times more experimental runs per day. The partnership is expected to improve throughput, reproducibility, and operational efficiency in laboratories conducting complex flow cytometry studies.
Why It's Important?
This collaboration represents a significant advancement in the field of drug discovery, as it leverages robotic automation to increase the efficiency and reliability of laboratory experiments. By enabling higher throughput and improved reproducibility, the integration of these technologies can accelerate the pace of research and development in the biopharmaceutical industry. This could lead to faster development of new therapies and drugs, ultimately benefiting patients and healthcare providers. Additionally, the collaboration highlights the growing importance of automation in scientific research, as laboratories seek to optimize their operations and reduce manual labor.
